Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Non-invasive different modalities of treatment for temporomandibular disorders: review of literature

  • Abouelhuda, Amira Mokhtar (Department of Prosthodontics, Mansoura University Hospital, College of Dentistry, Mansoura University) ;
  • khalifa, Ahmad Khalifa (Department of Prosthodontics, Mansoura University Hospital, College of Dentistry, Mansoura University) ;
  • Kim, Young-Kyun (Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Hegazy, Salah Abdelftah (Department of Prosthodontics, Mansoura University Hospital, College of Dentistry, Mansoura University)
  • Received : 2018.02.07
  • Accepted : 2018.02.08
  • Published : 2018.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Temporomandibular disorders (TMDs) are diseases that affect the temporomandibular joint and supporting structures. The goal of treatment for TMDs is elimination or reduction of pain and return to normal temporomandibular joint function. Initial treatment for TMDs is non-invasive and conservative, not surgical. Oral and maxillofacial surgeons should fully understand and actively care about non-invasive treatments for TMDs. The purpose of this study is to review the validity and outcomes of non-invasive and surgical treatment modalities for TMDs.

Keywords

References

  1. Carlson CR, Okeson JP, Falace DA, Nitz AJ, Curran SL, Anderson D. Comparison of psychologic and physiologic functioning between patients with masticatory muscle pain and matched controls. J Orofac Pain 1993;7:15-22.
  2. Wang X, Yang Z, Zhang W, Yi X, Liang C, Li X. Efficacy evaluation of low-level laser therapy on temporomandibular disorder. Hua Xi Kou Qiang Yi Xue Za Zhi 2011;29:393-5, 399.
  3. Sipahi A, Satilmis T, Basa S. Comparative study in patients with symptomatic internal derangements of the temporomandibular joint: analgesic outcomes of arthrocentesis with or without intraarticular morphine and tramadol. Br J Oral Maxillofac Surg 2015;53:316-20. https://doi.org/10.1016/j.bjoms.2014.12.018
  4. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009;32:1-32. https://doi.org/10.1146/annurev.neuro.051508.135531
  5. Cairns BE, Mann MK, Mok E, Dong XD, Svensson P. Diclofenac exerts local anesthetic-like actions on rat masseter muscle afferent fibers. Brain Res 2008;1194:56-64. https://doi.org/10.1016/j.brainres.2007.11.060
  6. Dina OA, Green PG, Levine JD. Role of interleukin-6 in chronic muscle hyperalgesic priming. Neuroscience 2008;152:521-5. https://doi.org/10.1016/j.neuroscience.2008.01.006
  7. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998;41:1591-602. https://doi.org/10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J
  8. Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W, et al. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther 1999;65:336-47. https://doi.org/10.1016/S0009-9236(99)70113-X
  9. Singer E, Dionne R. A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. J Orofac Pain 1997;11:139-46.
  10. Gottesdiener K, Mehlisch DR, Huntington M, Yuan WY, Brown P, Gertz B, et al. Efficacy and tolerability of the specific cyclooxygenase-2 inhibitor DFP compared with naproxen sodium in patients with postoperative dental pain. Clin Ther 1999;21:1301-12. https://doi.org/10.1016/S0149-2918(99)80031-9
  11. Ta LE, Dionne RA. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebocontrolled comparison of celecoxib to naproxen. Pain 2004;111:13-21. https://doi.org/10.1016/j.pain.2004.04.029
  12. Yap AU, Tan KB, Chua EK, Tan HH. Depression and somatization in patients with temporomandibular disorders. J Prosthet Dent 2002;88:479-84. https://doi.org/10.1067/mpr.2002.129375
  13. Falisi G, Rastelli C, Panti F, Maglione H, Quezada Arcega R. Psychotropic drugs and bruxism. Expert Opin Drug Saf 2014;13:1319-26. https://doi.org/10.1517/14740338.2014.947262
  14. Chang JP, Wu CC, Su KP. A case of venlafaxine-induced bruxism alleviated by duloxetine substitution. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:307. https://doi.org/10.1016/j.pnpbp.2010.11.025
  15. Herman CR, Schiffman EL, Look JO, Rindal DB. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. J Orofac Pain 2002;16:64-70.
  16. Rizzatti-Barbosa CM, Nogueira MT, de Andrade ED, Ambrosano GM, de Barbosa JR. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio 2003;21:221-5. https://doi.org/10.1080/08869634.2003.11746254
  17. Hersh EV, Balasubramaniam R, Pinto A. Pharmacologic management of temporomandibular disorders. Oral Maxillofac Surg Clin North Am 2008;20:197-210, vi. https://doi.org/10.1016/j.coms.2007.12.005
  18. Ownby SL, Fortuno LV, Au AY, Grzanna MW, Rashmir-Raven AM, Frondoza CG. Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination. J Inflamm (Lond) 2014;11:8. https://doi.org/10.1186/1476-9255-11-8
  19. Christiansen BA, Bhatti S, Goudarzi R, Emami S. Management of osteoarthritis with avocado/soybean unsaponifiables. Cartilage 2015;6:30-44. https://doi.org/10.1177/1947603514554992
  20. Halon A, Donizy P, Dziegala M, Dobrakowski R, Simon K. Tissue laser biostimulation promotes post-extraction neoangiogenesis in HIV-infected patients. Lasers Med Sci 2015;30:701-6. https://doi.org/10.1007/s10103-013-1411-5
  21. Ahrari F, Madani AS, Ghafouri ZS, Tuner J. The efficacy of lowlevel laser therapy for the treatment of myogenous temporomandibular joint disorder. Lasers Med Sci 2014;29:551-7. https://doi.org/10.1007/s10103-012-1253-6
  22. Bradley P. The maxillofacial region: recent research and clinical practice in low intensity laser therapy. In: Simunovic Z, ed. Lasers in medicine and dentistry: basic science and up-to-date clinical application of low energy-level laser therapy--LLLT. Rijeka: European Medical Laser Association; 2000:385-402.
  23. Kulekcioglu S, Sivrioglu K, Ozcan O, Parlak M. Effectiveness of low-level laser therapy in temporomandibular disorder. Scand J Rheumatol 2003;32:114-8. https://doi.org/10.1080/03009740310000139
  24. Coombe AR, Ho CT, Darendeliler MA, Hunter N, Philips JR, Chapple CC, et al. The effects of low level laser irradiation on osteoblastic cells. Clin Orthod Res 2001;4:3-14. https://doi.org/10.1034/j.1600-0544.2001.040102.x
  25. Pinheiro AL, Cavalcanti ET, Pinheiro TI, Alves MJ, Miranda ER, De Quevedo AS, et al. Low-level laser therapy is an important tool to treat disorders of the maxillofacial region. J Clin Laser Med Surg 1998;16:223-6.
  26. Mannheimer JS. Therapeutic modalities. In: Kraus SL, ed. TMJ disorders management of the craniomandibular complex. New York: Churchill Livingstone; 1988:311-37.
  27. Jankelson B, Radke JC. The myo-monitor: its use and abuse (I). Quintessence Int Dent Dig 1978;9:47-52.
  28. Pereira LJ, Gaviao MB, Bonjardim LR, Castelo PM, Andrade Ada S. Ultrasonography and electromyography of masticatory muscles in a group of adolescents with signs and symptoms of TMD. J Clin Pediatr Dent 2006;30:314-9. https://doi.org/10.17796/jcpd.30.4.w2t51jh08762648g
  29. Ariji Y, Katsumata A, Hiraiwa Y, Izumi M, Sakuma S, Shimizu M, et al. Masseter muscle sonographic features as indices for evaluating efficacy of massage treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:517-26. https://doi.org/10.1016/j.tripleo.2010.05.003
  30. El Fatih IA, Ibrahim AI, El Laithi A. Efficacy of physiotherapy and intraoral splint in the management of temporomandibular disorders. J Saudi Dent 2004;16:16-20.
  31. Esposito CJ, Veal SJ, Farman AG. Alleviation of myofascial pain with ultrasonic therapy. J Prosthet Dent 1984;51:106-8. https://doi.org/10.1016/S0022-3913(84)80115-8
  32. Santuzzi CH, Goncalves WLS, Rocha SS, Castro MEC, Gouvea SA, Abreu GR. Effects of cryotherapy, transcutaneous electrical stimulation and their combination on femoral nerve electrical activity in rats. Rev Bras Fisioter 2008;12:441-6.
  33. Deshpande RG, Mhatre S. TMJ disorders and occlusal splint therapy: a review. Int J Dent Clin 2010;2:22-9.
  34. Gray RJ, Davies SJ. Occlusal splints and temporomandibular disorders: why, when, how? Dent Update 2001;28:194-9. https://doi.org/10.12968/denu.2001.28.4.194
  35. Winocur E, Gavish A, Emodi-Perlman A, Halachmi M, Eli I. Hypnorelaxation as treatment for myofascial pain disorder: a comparative study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:429-34. https://doi.org/10.1067/moe.2002.122587
  36. Al-Ani MZ, Davies SJ, Gray RJ, Sloan P, Glenny AM. Stabilisation splint therapy for temporomandibular pain dysfunction syndrome. Cochrane Database Syst Rev 2004;(1):CD002778.
  37. Qvintus V, Suominen AL, Huttunen J, Raustia A, Ylostalo P, Sipila K. Efficacy of stabilisation splint treatment on facial pain: 1-year follow-up. J Oral Rehabil 2015;42:439-46. https://doi.org/10.1111/joor.12275
  38. Triantaffilidou K, Venetis G, Bika O. Efficacy of hyaluronic acid injections in patients with osteoarthritis of the temporomandibular joint. A comparative study. J Craniofac Surg 2013;24:2006-9. https://doi.org/10.1097/SCS.0b013e3182a30566
  39. Alpaslan GH, Alpaslan C. Efficacy of temporomandibular joint arthrocentesis with and without injection of sodium hyaluronate in treatment of internal derangements. J Oral Maxillofac Surg 2001;59:613-8; discussion 618-9. https://doi.org/10.1053/joms.2001.23368
  40. Long X, Chen G, Cheng AH, Cheng Y, Deng M, Cai H, et al. A randomized controlled trial of superior and inferior temporomandibular joint space injection with hyaluronic acid in treatment of anterior disc displacement without reduction. J Oral Maxillofac Surg 2009;67:357-61. https://doi.org/10.1016/j.joms.2008.09.014
  41. Alpaslan C, Bilgihan A, Alpaslan GH, Guner B, Ozgur Yis M, Erbas D. Effect of arthrocentesis and sodium hyaluronate injection on nitrite, nitrate, and thiobarbituric acid-reactive substance levels in the synovial fluid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:686-90. https://doi.org/10.1067/moe.2000.105518
  42. Sato S, Kawamura H. Changes in condylar mobility and radiographic alterations after treatment in patients with non-reducing disc displacement of the temporomandibular joint. Dentomaxillofac Radiol 2006;35:289-94. https://doi.org/10.1259/dmfr/92464710
  43. Sato S, Nasu F, Motegi K. Analysis of kinesiograph recordings and masticatory efficiency after treatment of non-reducing disk displacement of the temporomandibular joint. J Oral Rehabil 2003;30:708-13. https://doi.org/10.1046/j.1365-2842.2003.01122.x
  44. Sato S, Nasu F, Motegi K. Analysis of post-treatment electromyographs in patients with non-reducing disc displacement of the temporomandibular joint. J Oral Rehabil 2002;29:1126-30. https://doi.org/10.1046/j.1365-2842.2002.00996.x
  45. Basterzi Y, Sari A, Demirkan F, Unal S, Arslan E. Intraarticular hyaluronic acid injection for the treatment of reducing and nonreducing disc displacement of the temporomandibular joint. Ann Plast Surg 2009;62:265-7. https://doi.org/10.1097/SAP.0b013e31817dadb1
  46. Yeung RWK, Chow RLK, Samman N, Chiu K. Short-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:453-61. https://doi.org/10.1016/j.tripleo.2005.09.018
  47. Meunier FA, Schiavo G, Molgo J. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris 2002;96:105-13. https://doi.org/10.1016/S0928-4257(01)00086-9
  48. The Wealthy Dentist [Internet]. Tiburon (CA): The Wealthy Dentist [cited 2018 Feb 6]. Available from: http://thewealthydentist.com/.
  49. Emara AS, Faramawey MI, Hassaan MA, Hakam MM. Botulinum toxin injection for management of temporomandibular joint clicking. Int J Oral Maxillofac Surg 2013;42:759-64. https://doi.org/10.1016/j.ijom.2013.02.009
  50. Arinci A, Guven E, Yazar M, Basaran K, Keklik B. Effect of injection of botulinum toxin on lateral pterygoid muscle used together with the arthroscopy in patients with anterior disk displacement of the temporomandibular joint. Kulak Burun Bogaz Ihtis Derg 2009;19:122-9.
  51. Kim HS, Yun PY, Kim YK. A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg 2016;38:5. https://doi.org/10.1186/s40902-016-0051-7
  52. Moon YM, Kim YJ, Kim MK, Kim SG, Kweon H, Kim TW. Early effect of Botox-A injection into the masseter muscle of rats: functional and histological evaluation. Maxillofac Plast Reconstr Surg 2015;37:46. https://doi.org/10.1186/s40902-015-0049-6
  53. Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Br J Oral Maxillofac Surg 2013;51:199-205. https://doi.org/10.1016/j.bjoms.2012.07.002
  54. Park SY, Park YW, Ji YJ, Park SW, Kim SG. Effects of a botulinum toxin type A injection on the masseter muscle: an animal model study. Maxillofac Plast Reconstr Surg 2015;37:10. https://doi.org/10.1186/s40902-015-0010-8
  55. Song PC, Schwartz J, Blitzer A. The emerging role of botulinum toxin in the treatment of temporomandibular disorders. Oral Dis 2007;13:253-60. https://doi.org/10.1111/j.1601-0825.2007.01352.x
  56. Monje-Gil F, Nitzan D, Gonzalez-Garcia R. Temporomandibular joint arthrocentesis. Review of the literature. Med Oral Patol Oral Cir Bucal 2012;17:e575-81.
  57. Comert Kilic S, Gungormus M, Sumbullu MA. Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis alone in the treatment of temporomandibular joint osteoarthritis? A randomized clinical trial. J Oral Maxillofac Surg 2015;73:1473-83. https://doi.org/10.1016/j.joms.2015.02.026
  58. Davis CL, Kaminishi RM, Marshall MW. Arthroscopic surgery for treatment of closed lock. J Oral Maxillofac Surg 1991;49:704-7. https://doi.org/10.1016/S0278-2391(10)80232-0
  59. Stringer DE, Park CM. Single-cannula technique for operative arthroscopy using holmium:YAG laser. J Oral Maxillofac Surg 2012;70:49-50. https://doi.org/10.1016/j.joms.2011.07.021
  60. McCain JP, Hossameldin RH. Advanced arthroscopy of the temporomandibular joint. Atlas Oral Maxillofac Surg Clin North Am 2011;19:145-67. https://doi.org/10.1016/j.cxom.2011.06.001
  61. Moon SY, Chung H. Ultra-thin rigid diagnostic and therapeutic arthroscopy during arthrocentesis: development and preliminary clinical findings. Maxillofac Plast Reconstr Surg 2015;37:17. https://doi.org/10.1186/s40902-015-0018-0
  62. Indresano AT. Surgical arthroscopy as the preferred treatment for internal derangements of the temporomandibular joint. J Oral Maxillofac Surg 2001;59:308-12. https://doi.org/10.1053/joms.2001.21001
  63. Macho? V, Sedy J, Klima K, Hirjak D, Foltan R. Arthroscopic lysis and lavage in patients with temporomandibular anterior disc displacement without reduction. Int J Oral Maxillofac Surg 2012;41: 109-13. https://doi.org/10.1016/j.ijom.2011.07.907
  64. Smolka W, Iizuka T. Arthroscopic lysis and lavage in different stages of internal derangement of the temporomandibular joint: correlation of preoperative staging to arthroscopic findings and treatment outcome. J Oral Maxillofac Surg 2005;63:471-8. https://doi.org/10.1016/j.joms.2004.07.021
  65. Smolka W, Yanai C, Smolka K, Iizuka T. Efficiency of arthroscopic lysis and lavage for internal derangement of the temporomandibular joint correlated with Wilkes classification. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:317-23. https://doi.org/10.1016/j.tripleo.2007.12.007
  66. McCain JP, Sanders B, Koslin MG, Quinn JH, Peters PB, Indresano AT. Temporomandibular joint arthroscopy: a 6-year multicenter retrospective study of 4,831 joints. J Oral Maxillofac Surg 1992;50:926-30. https://doi.org/10.1016/0278-2391(92)90047-4
  67. Murakami KI, Tsuboi Y, Bessho K, Yokoe Y, Nishida M, Iizuka T. Outcome of arthroscopic surgery to the temporomandibular joint correlates with stage of internal derangement: five-year follow-up study. Br J Oral Maxillofac Surg 1998;36:30-4. https://doi.org/10.1016/S0266-4356(98)90744-6

Cited by

  1. Evaluation of Biofeedback Usefulness in Masticatory Muscle Activity Management-A Systematic Review vol.8, pp.6, 2018, https://doi.org/10.3390/jcm8060766
  2. Classification of the journal category "oral surgery" in the Scopus and the Science Citation Index Expanded: flaws and suggestions vol.45, pp.4, 2018, https://doi.org/10.5125/jkaoms.2019.45.4.186
  3. Emerging Potential of Exosomes in Regenerative Medicine for Temporomandibular Joint Osteoarthritis vol.21, pp.4, 2020, https://doi.org/10.3390/ijms21041541
  4. Short-Term Effects of Intra-Articular Hyaluronic Acid Administration in Patients with Temporomandibular Joint Disorders vol.9, pp.6, 2018, https://doi.org/10.3390/jcm9061749
  5. Photobiomodulation and Stem Cell Therapy for Temporomandibular Joint Disc Disorders vol.38, pp.7, 2018, https://doi.org/10.1089/photob.2019.4790
  6. An in vivo electromyographic evaluation of pain relief using different therapies in masticatory myalgia patients vol.46, pp.5, 2018, https://doi.org/10.5125/jkaoms.2020.46.5.321
  7. Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism vol.46, pp.5, 2020, https://doi.org/10.5125/jkaoms.2020.46.5.335
  8. Low-level laser therapy in temporomandibular joint disorders: a systematic review vol.14, pp.2, 2018, https://doi.org/10.25122/jml-2020-0169
  9. Comparative Evaluation of Occlusion before and after Soft Tissue Mobilization in Patients with Temporomandibular Disorder-Myofascial Pain with Referral vol.18, pp.12, 2018, https://doi.org/10.3390/ijerph18126568
  10. Temporomandibular Myofascial Pain Syndrome-Aetiology and Biopsychosocial Modulation. A Narrative Review vol.18, pp.15, 2018, https://doi.org/10.3390/ijerph18157807